The Roche Center of Excellence will provide highly potent dosage forms for preclinical, phase 1 and 2 clinical studies. The17,000ft² facility is equipped with specialized equipment which are
Clindamycin treats serious infections caused by susceptible anaerobic bacteria, besides treating infections due to susceptible strains of streptococci, pneumococci, and staphylococci. The latex-free injection which is expected to
Intellect will transfer all of Intellect’s intellectual property rights and data related to OX1 research and development program, to ViroPharma for $6.5m up-front licensing fee. The agreement has
During the course of the study, groups of mice were fed with specially formulated diets containing 5% freeze-dried blueberry powder, 10% blueberry powder or a control diet containing
During the course of the trial, 18 HIV-positive, treatment-naive patients will be treated with the drug for over 10 days. In addition, eight more patients will be given
The PDP is said to be a zero-dollar deductible Part D plan by the company. First Health Value Plus, built on preferred pharmacy networks, offers lower member co-payments
The clinic has opned a new department to conduct the study. Reveal will test the efficacy of the new drug Anacetrapib to boost HDL levels in patients 50
The EA will assess plant operation, macrolide branded generics and active pharmaceutical ingredients (API) production. The company should abide by regulatory guidelines in terms of surface and ground
The Proteus series of Proton Therapy solutions offer radiotherapy with fewer clinical consequences and is expected to treat 250 to 2,000 patients annually with protons. The solution comprises
At its new site, Diagnovus will develop diagnostic tests and offer information about rare forms of cancer, including pediatric cancers to physicians, payers, patients and families. The new
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.